| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Simard John, Director
Bought 70,000 shares ($143K) |
| 12 Nov 2026 | FORM 10-Q |
| 28 Oct 2026 |
Form 4: Simard Jan-Paul, Co-Chief Executive Officer
Granted 2,000,000 Stock Option |
| 28 Oct 2026 |
Form 3: Simard Jan-Paul, Co-Chief Executive Officer
No securities owned |
| 28 Oct 2026 |
Form 4: Simard John, Director
Bought 368,524 shares ($711K) |
| 26 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
XBiotech Inc. (“Company”) and Jan-Paul Simard (“Executive”) (collectively the “Parties”) hereby enter into this Executive Employment Agreement (the “Agreement”) on this 26th day of October, 2026 (the “Effective Date”). In consideration o... |
| 02 Oct 2026 | ARS |
| 02 Oct 2026 |
Proxy statement: annual meeting on November 24, 2026
say-on-pay vote |
| 13 Aug 2026 | FORM 10-Q |
| 14 May 2026 | FORM 10-Q |
| 29 Apr 2026 | FORM 10-K/A |
| 13 Mar 2026 | FORM 10-K |
| 11 Mar 2026 | FORM S-8 |
| 23 Jan 2026 | SCHEDULE 13G/A |
| 23 Jan 2026 | SCHEDULE 13G/A |
| 09 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
XBiotech, Inc. (“XBiotech” or the “Company”) announces that John Simard notified members of the Board of Directors beginning on December 5, 2025 of his intent to retire from his role as President and Chief Executive Officer of the Compan... |
| 12 Nov 2025 | FORM 10-Q |
| 12 Nov 2025 |
Form 4: Rademaker Craig Evan, Director
Granted 92,104 Director Stock Option |
| 12 Nov 2025 |
Form 4: Troy Tevi David, Director
Granted 56,000 Director Stock Option |
| 12 Nov 2025 |
Form 4: Soffer David Spencer, Director
Granted 51,000 Director Stock Option |
Loading...